Haemostasis is a process to stop the loss of blood and help in retaining the blood inside the damaged blood vessels. primary haemostasis, secondary haemostasis, and fibrinolysis are the types of haemostasis. When a blood vessel is wounded, platelets adhere to form a plug together. Proteins, known as coagulation factors, connect to develop a fibrin membrane to retain platelets in spot. This makes recovery process of the injury easy while hindering bloodless. According to National Trauma Institute Haemorrhage is responsible for more than 35% of pre-hospital deaths and more than 40% of deaths within the first 24 hours following a traumatic injury.
Increasing number of surgical procedures, growing incidence of sports-related injuries and increasing focus on effective blood loss management are some of the factors driving the growth of the market. However, high cost of haemostats and increase in product recall are hampering the growth of the market.
This report provides detailed study and revenue opportunity of haemostats across various segments such as products, types, application and region. Based on the products the market is segmented into thrombin-based haemostats, gelatin-based haemostats, collagen-based haemostats, oxidized regenerated, cellulose-based haemostats, combination haemostats and others. Based on the types the market is segmented into active haemostat, passive haemostat and combination haemostat. Based on the application the market is segmented into Surgical, Vascular, Dental, Military and others.
According to Infoholic Research, the “Global Haemostats” market is expected to grow at a CAGR of 6.0% – 8.0% during the forecast period 2019-2025.
The report provides details about the adoption of haemostats across various regions including Americas, Europe, Asia Pacific, and Middle East & Africa. The report also contains an in-depth analysis of vendor profiles, which includes financial health, business units, key business priorities, SWOT, strategies, and views of major players in the global medical tourism market. The market players included in the report are Advanced Medical Solutions, B. Braun Melsungen, Baxter International, C.R. Bard, Inc., CryoLife Inc., Integra LifeSciences, Pfizer, Gelita GmbH, Anika Therapeutics, Covidien Plc (Medtronic Plc), The Medicines Company, Vascular Solutions (Teleflex), Z-Medica, and Atrium Medical Corporation.
The study offers a comprehensive analysis of the “Haemostasis Market”, providing key insights of the industry. Also, the report aims to provide an opportunity for players to understand the latest trends, current market scenario, government initiatives, and technologies related to the market. In addition, it helps the venture capitalist in understanding the companies better and take informed decisions.